And why is it do you think these companies do deals with ASX biotechs when they are close to their annual/all time lows? Oh..I forgot...the current share price is irrelevant
TGN Tungsten has soared +700% YTD, the US is curbing its exports, and this ASX stock is targeting production in Q1CY27